title: Targeted molecular therapy for renal cell carcinoma.
authors.affiliation: Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
authors.forename: Brian R
authors.initials: BR
authors.lastname: Lane
authors.forename: Brian I
authors.initials: BI
authors.lastname: Rini
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Novick
authors.forename: Steven C
authors.initials: SC
authors.lastname: Campbell
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008967:Molecular Biology; D042442:Vascular Endothelial Growth Factors / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D042442:Vascular Endothelial Growth Factors